Works matching IS 15228517 AND DT 2014 AND VI 16 AND IP 5

Results: 25

Highlights from the Literature.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. 619, doi. 10.1093/neuonc/nou055
Publication type:: Article

Progression-free survival: too much risk, not enough reward?

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 615, doi. 10.1093/neuonc/nou041

By:

Alexander, Brian M.;
Trippa, Lorenzo

Publication type:

Article

Subscription Page.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. NP, doi. 10.1093/neuonc/not281
Publication type:: Article

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 662, doi. 10.1093/neuonc/not235

By:

Reyes-Botero, German;
Dehais, Caroline;
Idbaih, Ahmed;
Martin-Duverneuil, Nadine;
Lahutte, Marion;
Carpentier, Catherine;
Letouzé, Eric;
Chinot, Olivier;
Loiseau, Hugues;
Honnorat, Jerome;
Ramirez, Carole;
Moyal, Elisabeth;
Figarella-Branger, Dominique;
Ducray, François

Publication type:

Article

MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 637, doi. 10.1093/neuonc/not300

By:

Chen, Qiang;
Lu, Guohui;
Cai, Yingqian;
Li, Yufa;
Xu, Ruxiang;
Ke, Yiquan;
Zhang, Shizhong

Publication type:

Article

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997–2010.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 719, doi. 10.1093/neuonc/not316

By:

Nava, Francesca;
Tramacere, Irene;
Fittipaldo, Andrea;
Bruzzone, Maria Grazia;
DiMeco, Francesco;
Fariselli, Laura;
Finocchiaro, Gaetano;
Pollo, Bianca;
Salmaggi, Andrea;
Silvani, Antonio;
Farinotti, Mariangela;
Filippini, Graziella

Publication type:

Article

Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysis.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 728, doi. 10.1093/neuonc/not319

By:

Kinoshita, Manabu;
Sasayama, Takashi;
Narita, Yoshitaka;
Yamashita, Fumio;
Kawaguchi, Atsushi;
Chiba, Yasuyoshi;
Kagawa, Naoki;
Tanaka, Kazuhiro;
Kohmura, Eiji;
Arita, Hideyuki;
Okita, Yoshiko;
Ohno, Makoto;
Miyakita, Yasuji;
Shibui, Soichiro;
Hashimoto, Naoya;
Yoshimine, Toshiki

Publication type:

Article

Is there a role for vaccine-based therapy in recurrent glioblastoma?

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 757, doi. 10.1093/neuonc/nou031

By:

Chamberlain, Marc C.

Publication type:

Article

Society news.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. 761, doi. 10.1093/neuonc/nou061
Publication type:: Article

Erratum.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. 760, doi. 10.1093/neuonc/nou032
Publication type:: Article

Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 758, doi. 10.1093/neuonc/nou054

By:

Bloch, Orin;
Parsa, Andrew T.

Publication type:

Article

Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 748, doi. 10.1093/neuonc/not320

By:

Cefalo, Graziella;
Massimino, Maura;
Ruggiero, Antonio;
Barone, Giuseppe;
Ridola, Vita;
Spreafico, Filippo;
Potepan, Paolo;
Abate, Massimo E.;
Mascarin, Maurizio;
Garrè, Maria Luisa;
Perilongo, Giorgio;
Madon, Enrico;
Colosimo, Cesare;
Riccardi, Riccardo

Publication type:

Article

Lactate dehydrogenase A silencing in IDH mutant gliomas.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 686, doi. 10.1093/neuonc/not243

By:

Chesnelong, Charles;
Chaumeil, Myriam M.;
Blough, Michael D.;
Al-Najjar, Mohammad;
Stechishin, Owen D.;
Chan, Jennifer A.;
Pieper, Russell O.;
Ronen, Sabrina M.;
Weiss, Samuel;
Luchman, H. Artee;
Cairncross, J. Gregory

Publication type:

Article

Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 622, doi. 10.1093/neuonc/nou049

By:

Floyd, Desiree;
Purow, Benjamin

Publication type:

Article

Contents Page.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. NP, doi. 10.1093/neuonc/not293
Publication type:: Article

Cover Page.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. NP, doi. 10.1093/neuonc/not257
Publication type:: Article

Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 735, doi. 10.1093/neuonc/not325

By:

Domingues, Patrícia Henriques;
Sousa, Pablo;
Otero, Álvaro;
Gonçalves, Jesus Maria;
Ruiz, Laura;
de Oliveira, Catarina;
Lopes, Maria Celeste;
Orfao, Alberto;
Tabernero, Maria Dolores

Publication type:

Article

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 628, doi. 10.1093/neuonc/nou025

By:

Kaur, Gurvinder;
Sayegh, Eli T.;
Larson, Andrew;
Bloch, Orin;
Madden, Michelle;
Sun, Matthew Z.;
Barani, Igor J.;
James, C. David;
Parsa, Andrew T.

Publication type:

Article

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 707, doi. 10.1093/neuonc/nou004

By:

Widemann, Brigitte C.;
Dombi, Eva;
Gillespie, Andrea;
Wolters, Pamela L.;
Belasco, Jean;
Goldman, Stewart;
Korf, Bruce R.;
Solomon, Jeffrey;
Martin, Staci;
Salzer, Wanda;
Fox, Elizabeth;
Patronas, Nicholas;
Kieran, Mark W.;
Perentesis, John P.;
Reddy, Alyssa;
Wright, John J.;
Kim, AeRang;
Steinberg, Seth M.;
Balis, Frank M.

Publication type:

Article

MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 652, doi. 10.1093/neuonc/not307

By:

Yang, Guang;
Han, Dayong;
Chen, Xin;
Zhang, Daming;
Wang, Lu;
Shi, Chen;
Zhang, Weiguang;
Li, Chenguang;
Chen, Xiaofeng;
Liu, Huailei;
Zhang, Dongzhi;
Kang, Jianhao;
Peng, Fei;
Liu, Ziyi;
Qi, Jiping;
Gao, Xin;
Ai, Jing;
Shi, Changbin;
Zhao, Shiguang

Publication type:

Article

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 754, doi. 10.1093/neuonc/nou013

By:

Fathpour, Pakzad;
Obad, Nina;
Espedal, Heidi;
Stieber, Daniel;
Keunen, Olivier;
Sakariassen, Per Ø.;
Niclou, Simone P.;
Bjerkvig, Rolf

Publication type:

Article

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 696, doi. 10.1093/neuonc/not236

By:

Han, Kelong;
Ren, Melanie;
Wick, Wolfgang;
Abrey, Lauren;
Das, Asha;
Jin, Jin;
Reardon, David A.

Publication type:

Article

Editorial Board.

Published in:: Neuro-Oncology, 2014, v. 16, n. 5, p. NP, doi. 10.1093/neuonc/not269
Publication type:: Article

Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 671, doi. 10.1093/neuonc/not239

By:

Mahabir, Roshan;
Tanino, Mishie;
Elmansuri, Aiman;
Wang, Lei;
Kimura, Taichi;
Itoh, Tamio;
Ohba, Yusuke;
Nishihara, Hiroshi;
Shirato, Hiroki;
Tsuda, Masumi;
Tanaka, Shinya

Publication type:

Article

Plexiform neurofibromas, trial design, and the definitions of “progression” and “treatment failure”.

Published in:

Neuro-Oncology, 2014, v. 16, n. 5, p. 617, doi. 10.1093/neuonc/nou050

By:

Prados, Michael D.

Publication type:

Article